Page last updated: 2024-08-21

pyrazines and Cancer of Larynx

pyrazines has been researched along with Cancer of Larynx in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liang, YM; Liu, H; Wang, QW; Wang, T; Zhu, XD1
Yang, X1

Other Studies

2 other study(ies) available for pyrazines and Cancer of Larynx

ArticleYear
[Proteasome inhibitor bortezomib sensitizes Hep-2 human laryngeal squamous cell carcinoma cells to ionizing radiation in vitro and in vivo].
    Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2008, Volume: 43, Issue:6

    Topics: Animals; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Cell Line, Tumor; Enzyme Inhibitors; Female; Humans; Laryngeal Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Pyrazines; Radiation Tolerance; Radiation-Sensitizing Agents

2008
Proteasome inhibitor bortezomi-induced the apoptosis of laryngeal squamous cell carcinoma Hep-2 cell line via disrupting redox equilibrium.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2012, Volume: 66, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Caspase 3; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Humans; Laryngeal Neoplasms; Membrane Potential, Mitochondrial; Oxidation-Reduction; Oxidative Stress; Proteasome Inhibitors; Pyrazines; Reactive Oxygen Species

2012